Overview

LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC)

Status:
NOT_YET_RECRUITING
Trial end date:
2026-03-24
Target enrollment:
Participant gender:
Summary
A Phase 1b study to evaluate the safety and tolerability of LIV001 in Patients with Mild-to- Moderate Active Ulcerative Colitis
Phase:
PHASE1
Details
Lead Sponsor:
Liveome Inc.